Skip to main content

Strong Pharma Destination - India

India is rapidly becoming one of the best-considered settings for global pharma's drug research and development (R&D). Many factors have contributed to this outsourcing attraction, namely: highly-skilled doctors, trained paramedical staff, and a strong research infrastructure.
Strong Pharma Destination - India

Pharmaceutical consulting firms attribute the growth in pharma sales to transitional disease profiles, bigger access to medicines, and growing public health programs, and if the Indian economy keeps on growing, the local pharmaceutical market will experience a huge transformation in the years to come, reaching the top 10 around the year 2015. This will definitely have an impact on the global pharma industry in regards to R&D.
Previous estimations have valued India's research market between $600 million to $1 billion dollars, and global clinical trials performed in this country are expected to continue growing importantly in the next few years.
There are various reasons as to why India is such a desired location for research and development:
1. The amendments made in the past regarding the schedule Y of India's Drugs and Cosmetics Act of 1942 have turned the country into an attractive location for new trials. This amendment permits parallel trial conduct in India simultaneously with the rest of the world, eliminating, thus, the phase delay experienced before.
2. India is expected to be the most populated country by 2035, turning it into the youngest one. It holds 20% of the world's population under 24.
3. This country has a varied patient population in regards to race, culture, and economic level; and many are inexperienced about treatment. They are less prepared to deal with pneumonia, Hepatitis B, diabetes, or cancer, thus, the more patients, the higher recruitment quota. Shorter recruitment timelines prevail in India and patients' compliance is higher.
4. Many of the issues regarding patent protection and intellectual property rights are settled. India is compliant with the Trade Related Intellectual Property Rights Act (TRIPS). It holds a first-class data-processing infrastructure for biostatistics and bioinformatics, and huge generic drug-manufacturing facilities.
All of these are critical aspects of R&D costs, which have dramatically been increasing for the past few years. It is vital to streamlining the development process as much as possible. Even though there are no language barriers, US pharma-related companies desiring to get established in India will have to invest a great deal in education, given that 70% of the population lives in rural areas and the poor go to the public system for preventive and inpatient care. However, many of these patients also get involved in clinical trials for their urgent healthcare needs.

Despite its many strengths, India presents challenges as well:

1. There are just about 500 GCP-trained investigators with experience in clinical trials. India has considerably fewer physicians and beds than the world average. However, these are expected to double in the coming years due to private investment.
2. CRO's must have a well-structured IT system and a strongly-supported workflow strategy to back up the access to information in real time, and the monitoring, clinical liaison, and business development functions to control studies happening in other Indian sites.
3. CRO's may have to hire more personnel to manage rural sites and create a database of prime Indian investigators for indications and therapeutic areas, in order to meet international regulatory standards.
If you enjoyed this article about a Pharmaceutical consulting, please feel free to post it to your site or blog and forward this link to your friends. Have a great day!
If you are looking pharmaceutical export company in India, Visit Elfin, Elfin Drugs Pvt Ltd is one of the leading pharmaceutical export companies in India. We offer the worldwide Pharmaceutical Supply and Pharmacy Supplier services at the most competitive prices. We as the Indian pharmaceutical Exporter has been in the pharmaceutical business for many years and is committed to supplying genuine and top quality products to customers.

Labels:

Comments

Post a Comment

Popular posts from this blog

Difference between Contract Manufacturing and 3rd party Manufacturing Pharma

The company which outsources the manufacturing work keeps the duty of publicizing and promoting the merchandise and brand. When you get a superior partner, the remainder of the things becomes easy. The pharma provider will get quality products if a trustworthy and knowledgeable third-party manufacturer is selected. Similarly, it can outsource the same drug to different manufacturers. Businesses are finding many reasons why they ought to outsource their production to other businesses. The world's leading businesses are trying to find the world's very best ideas and are ready to go anywhere and everywhere to locate them. For smaller businesses, contract manufacturing might not be a very good small business strategy. Though contract manufacturing is comparable to toll manufacturing, there are a few key differences between both. Generally, contract pharma manufacturing is acceptable for a business that already produces food products alone and has a recognizable br
18 comments
Read more

Guidance on good manufacturing practice and good distribution practice

You are going to be inspected when you submit an application for a manufacturer or wholesaler dealer licence and periodically based on risk assessments. You're going to be inspected when you make an application for a manufacturer or wholesaler dealer license and after that periodically based on risk assessments.  Elfin Drugs Pvt. Ltd . is WHO & GMP certified company, We are sharing information about g uidance on good manufacturing practice . We deal in third party manufacturing pharma company .  It's the business's responsibility to find out the best and effective excellent procedure. It's the business's responsibility to ascertain the best and effective high quality process that both meets business and regulatory needs. In so doing, the consumer is shielded from purchasing and utilizing an item which isn't powerful or perhaps is dangerous. Drug distribution has special security considerations. It is the process by means of which people get access to m
Post a Comment
Read more

Wholesale Pharmaceuticals

Pharmacists will need to turn in an application for a wholesale dealer license if they would like to supply medicines to anyone besides directly to the general public. Huge pharmacies have entered into multifaceted partnerships with wholesalers Larger pharmacies finally have a new amount of top-to-top partnering that's securing wholesalers' part in the distribution system. Wholesale pharmaceuticals are usually supplied with the very best possible expiry date at the right time of sale. If you are looking company for third party medicine manufacturers in India , you can contact Elfin Drugs Pvt. Ltd. Some drugs in the marketplace might not have a generic brand just yet. Moreover, in some instances, it's cheaper to obtain these medications over-the-counter than with a prescription from the physician. Patients that are on Losartan should carry on taking their medication, as the danger of harm to the patient's health might be higher if the treatment is stopped imme
Post a Comment
Read more